Strategy for clinical setting in intramuscular and subcutaneous islet transplantation

Diabetes/Metabolism Research and Reviews

Volumn 30, Issue 1, 2014, Pages 1-10

  Sakata, Naoaki ^a   Aoki, Takeshi ^a   Yoshimatsu, Gumpei ^a   Tsuchiya, Haruyuki ^a   Hata, Tatsuo ^a   Katayose, Yu ^a   Egawa, Shinichi ^a   Unno, Michiaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Intramuscular; Islet transplantation; Subcutaneous; Transplant site

Indexed keywords

ALGINIC ACID;

ANGIOGENESIS; CELL ENCAPSULATION; DIABETES MELLITUS; GLYCEMIC CONTROL; HUMAN; HYPOXEMIA; INTRAMUSCULAR ISLET TRANSPLANTATION; INTRAPORTAL ISLET TRANSPLANTATION; MUSCLE TISSUE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS ISLET TRANSPLANTATION; SUBCUTANEOUS TISSUE; TRANSPLANT SITE; TRANSPLANTATION; TREATMENT OUTCOME; VASCULARIZATION;

INTRAMUSCULAR; ISLET TRANSPLANTATION; SUBCUTANEOUS; TRANSPLANT SITE;

ANIMALS; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; ISLETS OF LANGERHANS TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84892474312     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2463     Document Type: Review

References (94)

1. Sutherland DE, Matas AJ, Goetz FC, Najarian JS. Transplantation of dispersed pancreatic islet tissue in humans: autografts and allografts. Diabetes 1980; 29(Suppl 1): 31.
2. Rajab A. Islet transplantation: alternative sites. Curr Diabetes Rep 2010; 10(5): 332.
3. Gao F, Ai SD, Liu S, Zeng WB, Wang W. Percutaneous transhepatic portal catheterization guided by ultrasound technology for islet transplantation in rhesus monkey. Hepatobiliary Pancreat Dis Int 2012; 11(2): 154.
4. Johansson H, Lukinius A, Moberg L, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005; 54(6): 1755.
5. Moberg L, Olsson A, Berne C, et al. Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation. Transplantation 2003; 76(9): 1285.
6. Bottino R, Fernandez LA, Ricordi C, et al. Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 1998; 47(3): 316.
7. Fu Y, Lu X, Yi S, et al. Selective rejection of porcine islet xenografts by macrophages. Xenotransplantation 2008; 15(5): 307.
8. Ishiyama K, Rawson J, Omori K, Mullen Y. Liver natural killer cells play a role in the destruction of islets after intraportal transplantation. Transplantation 2011; 91(9): 952.
9. Schramm R, Scheuer C, Yamauchi J, Vollmar B, Menger MD. Heat shock preconditioning impairs revascularization of freely transplanted pancreatic islets. Transplantation 2002; 74(11): 1544.
10. Vajkoczy P, Olofsson AM, Lehr HA, et al. Histogenesis and ultrastructure of pancreatic islet graft microvasculature. Evidence for graft revascularization by endothelial cells of host origin. Am J Pathol 1995; 146(6): 1397.
11. Dionne KE, Colton CK, Yarmush ML. Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes 1993; 42(1): 12.
12. Sakata N, Obenaus A, Chan N, Mace J, Chinnock R, Hathout E. Factors affecting islet graft embolization in the liver of diabetic mice. Islets 2009; 1(1): 26.
13. Sakata N, Hayes P, Tan A, et al. MRI assessment of ischemic liver after intraportal islet transplantation. Transplantation 2009; 87(6): 825.
14. Shivaswamy V, McClure M, Passer J, et al. Hyperglycemia induced by tacrolimus and sirolimus is reversible in normal sprague-dawley rats. Endocrine 2010; 37(3): 489.
15. Desai NM, Goss JA, Deng S, et al. Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation 2003; 76(11): 1623.
16. Maffi P, Angeli E, Bertuzzi F, et al. Minimal focal steatosis of liver after islet transplantation in humans: a long-term study. Cell Transplan 2005; 14(10): 727.
17. Ryan EA, Lakey JR, Paty BW, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51(7): 2148.
18. Kawahara T, Kin T, Shapiro AM. A comparison of islet autotransplantation with allotransplantation and factors elevating acute portal pressure in clinical islet transplantation. J Hepatobiliary Pancreat Sci 2012; 19(3): 281.
19. Thomas RM, Ahmad SA. Management of acute post-operative portal venous thrombosis. J Gastrointest Surg 2010; 14(3): 570.
20. Kawahara T, Kin T, Kashkoush S, et al. Portal vein thrombosis is a potentially preventable complication in clinical islet transplantation. Am J Transplant 2011; 11(12): 2700.
21. Villiger P, Ryan EA, Owen R, et al. Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant 2005; 5(12): 2992.
22. Sakata N, Chan NK, Chrisler J, Obenaus A, Hathout E. Bone marrow cell cotransplantation with islets improves their vascularization and function. Transplantation 2010; 89(6): 686.
23. Sakata N, Kodama T, Chen R, et al. Monitoring transplanted islets by high-frequency ultrasound. Islets 2011; 3(5): 259.
24. Sakata N, Tan A, Chan N, et al. Efficacy comparison between intraportal and subcapsular islet transplants in a murine diabetic model. Transplant Proc 2009; 41(1): 346.
25. Ar'Rajab A, Ahren B, Alumets J, Bengmark S. Islet transplantation to the renal subcapsular space in streptozotocin-diabetic rats. Long-term effects on insulin and glucagon secretion. Acta Chir Scand 1989; 155(10): 503.
26. Ar'Rajab A, Ahren B, Alumets J, Logdberg L, Bengmark S. Islet transplantation to the renal subcapsular space improves late complications in streptozotocin-diabetic rats. Eur Surg Res 1990; 22(5): 270.
27. Kin T, Korbutt GS, Rajotte RV. Survival and metabolic function of syngeneic rat islet grafts transplanted in the omental pouch. Am J Transplant 2003; 3(3): 281.
28. Sakata N, Chan NK, Chrisler J, Obenaus A, Hathout E. Bone marrow cells produce nerve growth factor and promote angiogenesis around transplanted islets. WJG 2010; 16(10): 1215.
29. Sakata N, Goto M, Yoshimatsu G, Egawa S, Unno M. Utility of co-transplanting mesenchymal stem cells in islet transplantation. WJG 2011; 17(47): 5150.
30. Salazar-Banuelos A, Wright J, Sigalet D, Benitez-Bribiesca L. The bone marrow as a potential receptor site for pancreatic islet grafts. Arch Med Res 2008; 39(1): 139.
31. Salazar-Banuelos A, Wright JR Jr, Sigalet D, Benitez-Bribiesca L. Pancreatic islet transplantation into the bone marrow of the rat. Am J Surg 2008; 195(5): 674.
32. Espes D, Eriksson O, Lau J, Carlsson PO. Striated muscle as implantation site for transplanted pancreatic islets. J Transplant 2011; 2011: 352043.
33. Stegall MD. Monitoring human islet allografts using a forearm biopsy site. Ann Transplant 1997; 2(3): 8.
34. Tominaga Y, Uchida K, Haba T, et al. More than 1, 000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis 2001; 38(4 Suppl 1): S168.
35. Weber CJ, Hardy MA, Pi-Sunyer F, Zimmerman E, Reemtsma K. Tissue culture preservation and intramuscular transplantation of pancreatic islets. Surgery 1978; 84(1): 166.
36. Axen KV, Pi-Sunyer FX. Long-term reversal of streptozotocin-induced diabetes in rats by intramuscular islet implantation. Transplantation 1981; 31(6): 439.
37. Simeonovic CJ, Dhall DP, Wilson JD, Lafferty KJ. A comparative study of transplant sites for endocrine tissue transplantation in the pig. Aust J Exp Biol Med Sci 1986; 64(Pt 1): 37.
38. Tze WJ, Tai J. Allotransplantation of dispersed single pancreatic endocrine cells in diabetic rats. Diabetes 1988; 37(4): 383.
39. Svensson J, Lau J, Sandberg M, Carlsson PO. High vascular density and oxygenation of pancreatic islets transplanted in clusters into striated muscle. Cell Transplant 2011; 20(5): 783.
40. Kim HI, Yu JE, Park CG, Kim SJ. Comparison of four pancreatic islet implantation sites. J Kor Med Sci 2010; 25(2): 203.
41. Lund T, Korsgren O, Aursnes IA, Scholz H, Foss A. Sustained reversal of diabetes following islet transplantation to striated musculature in the rat. J Surg Res 2010; 160(1): 145.
42. Adams GA, Wang X, Lee LK, Piercy CE, Alfrey EJ, Dafoe DC. Insulin-like growth factor-I promotes successful fetal pancreas transplantation in the intramuscular site. Surgery 1994; 116(4): 751.
43. Adams GA, Maestri M, Squiers EC, Alfrey EJ, Starzl TE, Dafoe DC. Augmenter of liver regeneration enhances the success rate of fetal pancreas transplantation in rodents. Transplantation 1998; 65(1): 32.
44. Christoffersson G, Vagesjo E, Vandooren J, et al. VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue. Blood 2012; 120(23): 4653.
45. Balamurugan AN, Gu Y, Tabata Y, et al. Bioartificial pancreas transplantation at prevascularized intermuscular space: effect of angiogenesis induction on islet survival. Pancreas 2003; 26(3): 279.
46. Witkowski P, Sondermeijer H, Hardy MA, et al. Islet grafting and imaging in a bioengineered intramuscular space. Transplantation 2009; 88(9): 1065.
47. Christoffersson G, Carlsson PO, Phillipson M. Intramuscular islet transplantation promotes restored islet vascularity. Islets 2011; 3(2): 69.
48. Yang KC, Wu CC, Kuo ZF, Yang CY, Lin FH. Intramedullary cavity as implantation site for bioartifical pancreas: preliminary in vivo study. Transplant Proc 2010; 42(7): 2666.
49. Yang KC, Wu CC, Qi Z, Chen JC, Sumi S, Lin FH. Comparison of bioartificial pancreas performance in the bone marrow cavity and intramuscular space. Arch Med Sci 2010; 41(3): 151.
50. Delaunay C, Honiger J, Darquy S, Capron F, Reach G. Bioartificial pancreas containing porcine islets of Langerhans implanted in low-dose streptozotocin-induced diabetic mice: effect of encapsulation medium. Diabetes Metabol 1997; 23(3): 219.
51. Medarova Z, Vallabhajosyula P, Tena A, et al. In vivo imaging of autologous islet grafts in the liver and under the kidney capsule in non-human primates. Transplantation 2009; 87(11): 1659.
52. Djordjevic PB, Lalic NM, Jotic A, et al. Human fetal islet transplantation in type 1 diabetic patients: comparison of metabolic effects between single and multiple implantation regimens. Transplant Proc 2004; 36(9): 2869.
53. Rafael E, Tibell A, Ryden M, et al. Intramuscular autotransplantation of pancreatic islets in a 7-year-old child: a 2-year follow-up. Am J Transplant 2008; 8(2): 458.
54. Dardenne S, Sterkers A, Leroy C, et al. Laparoscopic spleen-preserving distal pancreatectomy followed by intramuscular autologous islet transplantation for traumatic pancreatic transection in a young adult. JOP 2012; 13(3): 285.
55. Saito T, Ohashi K, Utoh R, et al. Reversal of diabetes by the creation of neo-islet tissues into a subcutaneous site using islet cell sheets. Transplantation 2011; 92(11): 1231.
56. Lacy PE, Hegre OD, Gerasimidi-Vazeou A, Gentile FT, Dionne KE. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 1991; 254(5039): 1782.
57. Scharp DW, Swanson CJ, Olack BJ, et al. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes 1994; 43(9): 1167.
58. Juang JH, Bonner-Weir S, Ogawa Y, Vacanti JP, Weir GC. Outcome of subcutaneous islet transplantation improved by polymer device. Transplantation 1996; 61(11): 1557.
59. Figliuzzi M, Cornolti R, Plati T, et al. Subcutaneous xenotransplantation of bovine pancreatic islets. Biomaterials 2005; 26(28): 5640.
60. Federlin K, Slijepcevic M, Helmke K. Islet transplantation in experimental diabetes of the rat. IV. The influence of transplantation site and of histocompatibility on islet function. Horm Metab Res 1976; 8(2): 97.
61. Kramp RC, Cuche R, Renold AE. Subcutaneous, isogeneic transplantation of either duct-ligated pancreas or isolated islets in streptozotocin diabetic mice. Endocrinology 1976; 99(5): 1161.
62. Fumimoto Y, Matsuyama A, Komoda H, et al. Creation of a rich subcutaneous vascular network with implanted adipose tissue-derived stromal cells and adipose tissue enhances subcutaneous grafting of islets in diabetic mice. Tissue Eng Part C Methods 2009; 15(3): 437.
63. Kerby A, Bohman S, Westberg H, Jones P, King A. Immunoisolation of islets in high guluronic acid barium-alginate microcapsules does not improve graft outcome at the subcutaneous site. Artif Organs 2012; 36(6): 564.
64. Borud LJ, Shaw WW, Brunicardi FC, Mullen Y, Passaro EP Jr. Prefabrication of a neo-endocrine organ: a rat model. J Surg Res 1996; 61(1): 221.
65. Kawakami Y, Iwata H, Gu Y, et al. Modified subcutaneous tissue with neovascularization is useful as the site for pancreatic islet transplantation. Cell Transplant 2000; 9(5): 729.
66. Perez-Basterrechea M, Briones RM, Alvarez-Viejo M, et al. Plasma-fibroblast gel as scaffold for islet transplantation. Tissue Eng Part A 2009; 15(3): 569.
67. Juang JH, Hsu BR, Kuo CH. Islet transplantation at subcutaneous and intramuscular sites. Transplant Proc 2005; 37(8): 3479.
68. Tatarkiewicz K, Hollister-Lock J, Quickel RR, Colton CK, Bonner-Weir S, Weir GC. Reversal of hyperglycemia in mice after subcutaneous transplantation of macroencapsulated islets. Transplantation 1999; 67(5): 665.
69. Gu Y, Tabata Y, Kawakami Y, et al. Development of a new method to induce angiogenesis at subcutaneous site of streptozotocin-induced diabetic rats for islet transplantation. Cell Transplant 2001; 10(4-5): 453.
70. Kawakami Y, Iwata H, Gu YJ, et al. Successful subcutaneous pancreatic islet transplantation using an angiogenic growth factor-releasing device. Pancreas 2001; 23(4): 375.
71. Sakurai T, Satake A, Nagata N, et al. The development of new immunoisolatory devices possessing the ability to induce neovascularization. Cell Transplant 2003; 12(5): 527.
72. Wang W, Gu Y, Tabata Y, et al. Reversal of diabetes in mice by xenotransplantation of a bioartificial pancreas in a prevascularized subcutaneous site. Transplantation 2002; 73(1): 122.
73. Pileggi A, Molano RD, Ricordi C, et al. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 2006; 81(9): 1318.
74. Kriz J, Jirak D, Vilk GJ, et al. Vascularization of artificial beds for pancreatic islet transplantation in a rat model. Transplant Proc 2010; 42(6): 2097.
75. Kriz J, Jirak D, Koblas T, et al. Dynamic contrast-enhanced magnetic resonance imaging as a tool to monitor the blood supply to an artificial cavity used as a site for islet transplantation in rats. Transplant Proc 2011; 43(9): 3226.
76. Bharat A, Benshoff N, Olack B, Ramachandran S, Desai NM, Mohanakumar T. Novel in vivo murine model to study islet potency: engraftment and function. Transplantation 2005; 79(11): 1627.
77. Golocheikine A, Tiriveedhi V, Angaswamy N, Benshoff N, Sabarinathan R, Mohanakumar T. Cooperative signaling for angiogenesis and neovascularization by VEGF and HGF following islet transplantation. Transplantation 2010; 90(7): 725.
78. Deng C, Vulesevic B, Ellis C, Korbutt GS, Suuronen EJ. Vascularization of collagen-chitosan scaffolds with circulating progenitor cells as potential site for islet transplantation. J Control Release 2011; 152(Suppl 1): e196.
79. Kim JS, Lim JH, Nam HY, et al. In situ application of hydrogel-type fibrin-islet composite optimized for rapid glycemic control by subcutaneous xenogeneic porcine islet transplantation. J Control Release 2012; 162(2): 382.
80. Andrades P, Asiedu C, Rodriguez C, Goodwin KJ, McCarn J, Thomas JM. Subcutaneous pancreatic islet transplantation using fibrin glue as a carrier. Transplant Proc 2007; 39(1): 191.
81. Veriter S, Aouassar N, Adnet PY, et al. The impact of hyperglycemia and the presence of encapsulated islets on oxygenation within a bioartificial pancreas in the presence of mesenchymal stem cells in a diabetic Wistar rat model. Biomaterials 2011; 32(26): 5945.
82. Shimizu H, Ohashi K, Utoh R, et al. Bioengineering of a functional sheet of islet cells for the treatment of diabetes mellitus. Biomaterials 2009; 30(30): 5943.
83. Dufrane D, Goebbels RM, Gianello P. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6months without immunosuppression. Transplantation 2010; 90(10): 1054.
84. Lamb M, Storrs R, Li S, et al. Function and viability of human islets encapsulated in alginate sheets: in vitro and in vivo culture. Transplant Proc 2011; 43(9): 3265.
85. Bobzien B, Yasunami Y, Majercik M, Lacy PE, Davie JM. Intratesticular transplants of islet xenografts (rat to mouse). Diabetes 1983; 32(3): 213.
86. Tze WJ, Tai J. Intracerebral allotransplantation of purified pancreatic endocrine cells and pancreatic islets in diabetic rats. Transplantation 1984; 38(2): 107.
87. Posselt AM, Barker CF, Tomaszewski JE, Markmann JF, Choti MA, Naji A. Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 1990; 249(4974): 1293.
88. Heuser M, Wolf B, Vollmar B, Menger MD. Exocrine contamination of isolated islets of Langerhans deteriorates the process of revascularization after free transplantation. Transplantation 2000; 69(5): 756.
89. Guan J, Zucker PF, Behme MT, Zhong R, Atkinson P, Dupre J. Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts. Diabetes 1997; 46(3): 372.
90. Diem P, Abid M, Redmon JB, Sutherland DE, Robertson RP. Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes 1990; 39(5): 534.
91. Kruszynska YT, Home PD, Alberti KG. Comparison of portal and peripheral insulin delivery on carbohydrate metabolism in streptozotocin-diabetic rats. Diabetologia 1985; 28(3): 167.
92. al-Abdullah IH, Anil Kumar MS, Kelly-Sullivan D, Abouna GM. Site for unpurified islet transplantation is an important parameter for determination of the outcome of graft survival and function. Cell Transplant 1995; 4(3): 297.
93. Christoffersson G, Henriksnas J, Johansson L, et al. Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets. Diabetes 2010; 59(10): 2569.
94. Marzorati S, Bocca N, Molano RD, et al. Effects of systemic immunosuppression on islet engraftment and function into a subcutaneous biocompatible device. Transplant Proc 2009; 41(1): 352.